ネバダ州における2型糖尿病の臨床試験
ネバダ州内の拠点で、2型糖尿病に関する18件の研究が参加者を募集しています。
ネバダ州内の都市
公式研究テキスト（英語）
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Palm Research Center, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Las Vegas Clinical Trials, Las Vegas
- AB Clinical Trials, Las Vegas
- Palm Research Center, Las Vegas
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Excel Clinical Research, LLC, Las Vegas
- Palm Research Center Tenaya, Las Vegas
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Palm Research Center Inc-Vegas, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07817251A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Southwest Medical Associates- Optum Nevada, Las Vegas
- Vector Clinical Trials, Las Vegas
被験者募集中健康なボランティア歓迎
55歳以上 · 全性別 · 2026/09/28更新 · NCT06112418A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07776509A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- DaVita Clinical Research, Las Vegas
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/11更新 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Henderson
- Research Site, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Alliance Clinical - Las Vegas, Las Vegas
- Palm Research Center, Inc., Las Vegas
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07296484A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Vector Clinical Trials, Las Vegas
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT07215559Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Palm Research Center Inc, Las Vegas
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Palm Research Center Inc-Vegas, Las Vegas
被験者募集中第3相
45歳以上 · 全性別 · 2026/09/01更新 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/31更新 · NCT07662044Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Santa Rosa Medical Centers of Nevada, Las Vegas
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/17更新 · NCT07527650Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Excel Clinical Research, Las Vegas
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/06/15更新 · NCT07502508HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Alliance Clinical Las Vegas (Excel Clinical Research), Las Vegas
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/23更新 · NCT07546929ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。